AzTrials
AzTrials

Ineffective MotilityNCT00680030

Reversibility of Dysmotility After Gastric Banding

An observational study of Ineffective Motility and Diffuse Esophageal Spasms, run by Cantonal Hospital of St. Gallen at 1 site in Switzerland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the current study we plan to evaluate the effects of the conversion from gastric banding to gastric bypass on esophageal function using combined monitoring. The primary aim of the current study is to evaluate esophageal function before and 3-months after the conversion from gastric banding to gastric bypass. Read more about this study

Who is it for?
Ages 18 to 70 years
How many people
50 participants
Where
1 siteSwitzerland
Study dates
Sep 2007to Dec 2008
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Morbidly obese patients in whom a conversion from gastric band to gastric bypass is planed

Who may be able to join

  • Patients in whom a conversion from gastric band to gastric bypass is planed

Who cannot join

  • Acute cardiac or pulmonary conditions
  • Antireflux surgery or antireflux endoscopic procedures.
  • Patients unable to provide informed consent

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Cantonal Hospital St. Gallen

    Sankt Gallen, Canton of St. Gallen

Other trials in Switzerland

About this study

Official title: Reversibility of Esophageal Dysmotilities Associated With Gastric Banding After Conversion to Gastric Bypass

In the current study we plan to evaluate the effects of the conversion from gastric banding to gastric bypass on esophageal function using combined monitoring. The primary aim of the current study is to evaluate esophageal function before and 3-months after the conversion from gastric banding to gastric bypass. A second objective is to evaluate the severity of symptoms, esophageal dysmotilities, endoscopic abnormalities and bolus retention found in patients referred for conversion from gastric banding to gastric bypass. Our hypothesis is that esophageal motility disorders associated with gastric banding are reversed by conversion to gastric bypass.

Read the detailed description

2.2.3 Research plan

As model for this study we propose a longitudinal single-center study design with testing before and after the surgical intervention.

Participants

The study population will be limited to patients considered for gastric banding to gastric by-pass conversion. Patients will be recruited from the surgical out-patient clinic

Testing during the study period

Pre-OP 3 months post-OP Symptom evaluation X X Endoscopy X X Upper GI series X X Combined MII-EM X X

OP - conversion of gastric band to gastric bypass

After providing informed consent the volunteers will be screened for inclusion/exclusion criteria. Participants fulfilling the inclusion/exclusion criteria will undergo baseline symptom evaluation, endoscopy, an upper GI series and esophageal function testing using combined MII-EM as part of the pre-operative work-up. The same examinations (symptom evaluation, endoscopy, upper GI series and esophageal function testing) will be repeated 3 months after successful conversion from gastric band to bypass.

Symptom evaluation Patients will be asked to complete a standardized esophageal symptom questionnaire. This questionnaire evaluates the frequency and severity of heartburn, chest pain, regurgitation and dysphagia which are then computed into a composite score (Eraflux score ).

Endoscopy Standard sedated endoscopy will be performed by a trained gastroenterologist. The endoscopy will be performed according to the standard clinical protocol. During endoscopy the examiner will pay particular attention to the esophageal mucosa, the size of the gastric pouch above the band (baseline examination), the size of the gastric pouch above the gastro-jejunal anastomosis (post-operative examination), the presence of ulcerations at the site of gastric banding/gastric bypass.

Upper GI Series Patients will undergo upper GI series using a modified timed-barium swallow (achalasia) protocol. Patients will receive 100ml liquid barium and PA images focused on the GE junction will be taken immediately after swallowing, 1 and 3 minutes later. These sequences should allow determining the position of the band relative to the GE junction and the size of the gastric pouch above the gastro-jejunal anastomosis.

Esophageal function testing (EFT)

On the day of esophageal motility testing an EFT probe will be placed transnasally through the esophagus into the stomach and the LES location and pressure will be determined by stationary pull-through technique. The most distal circumferential pressure sensor will be placed in the high-pressure zone (HPZ) of the LES. The other measuring sites (both pressure and impedance) will be subsequently at 5, 10, 15 and 20 cm above the HPZ of the LES. Ten swallows (5 cc each) of liquid (0.9% normal saline) and 10 swallows (5 cc each) of a standard viscous material (EFT viscous, Sandhill Scientific, Inc) will be given with each swallow 20-30 seconds apart.

Analyzed parameters:

  • Bolus transit time (BTT): time interval (sec) between bolus entry at the proximal measuring segment and bolus exit at the distal segment
  • Smooth muscle bolus transit time (SMBTT): time interval (sec) between bolus entry at the second most distal measuring segment and bolus exit at the distal segment
  • Contraction amplitude at 5, 10, 15 and 20 cm above the HPZ
  • Distal esophageal amplitude (DEA): average amplitude of contraction at 5 and 10cm above HPZ
  • Onset velocity of contractions: contraction velocity between 5 and 10 cm above the HPZ
  • LES mid-respiratory resting pressure measured during station pull-through
  • Average LES residual pressure during swallowing

Data analysis

Proportions (i.e. percentage of patients with esophageal dysmotility, patients with ulcerations at the banding/anastomosis site, etc.) will be compared using McNemar test. Continuous parameters (i.e. symptom scores, esophageal manometry and bolus transit data) recorded prior and 3-months after the conversion will be compared using paired T-tests. For statistical significance alpha will be set at 0.05.

Sample size calculation Assuming that esophageal dysmotilities are present in 50% of patients prior to the conversion of banding to bypass and that conversion reduces this proportion by 50% we calculated that 40 complete datasets would be required for an 85% power to identify this change. Allowing a drop-out rate of 20% we plan to enroll 50 patients in the present study.

Keywords
impedance, manometry, motility disorders, ineffective motility, diffuse esophageal spasms, achlasia-like dysmotility
Medical subject headings
Esophageal Spasm, Diffuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00680030
Study groupRoleWhat they receive
1Not described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. reversibility of dysmotility after surgery

    Measured: 3 months

Secondary outcomes (1)
  1. degree of dysmoztility after gastric banding

    Measured: not defined

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2008 (estimated)
  2. Study startSep 2007
  3. Primary completionSep 2008 (estimated)
  4. Study completionDec 2008 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00680030
Sponsor's protocol ID
EKSG 06/91
Status last verified
May 2008
First submitted
15 May 2008
Last updated
19 May 2008
Results posted
No
Data monitoring committee
Yes

Publications

  • Borovicka J, Krieger-Grubel C, van der Weg B, Thurnheer M, Schultes B, Sulz MC, Gutzwiler JP, Bisang P, Pohl D, Fried M, Meyenberger C, Tutuian R. Effect of morbid obesity, gastric banding and gastric bypass on esophageal symptoms, mucosa and function. Surg Endosc. 2017 Feb;31(2):552-560. doi: 10.1007/s00464-016-4996-5. Epub 2016 Jun 10.

    PubMed 27287911

Questions about this trial

What is this clinical trial studying?

An observational study of Ineffective Motility and Diffuse Esophageal Spasms, run by Cantonal Hospital of St. Gallen at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 May 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

reversibility of dysmotility after surgery (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00680030, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in